ALDEYRA THERAPEUTICS INC (ALDX) Forecast, Price Target & Analyst Ratings

NASDAQ:ALDX • US01438T1060

Current stock price

1.8 USD
0 (0%)
At close:
1.77 USD
-0.03 (-1.67%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALDEYRA THERAPEUTICS INC (ALDX).

Forecast Snapshot

Consensus Price Target

Price Target
$7.34
+ 308.00% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 5, 2026
Period
Q2 / 2026
EPS Estimate
-$0.14
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.34
Upside
+ 308.00%
From current price of $1.80 to mean target of $7.34, Based on 12 analyst forecasts
Low
$2.02
Median
$7.14
High
$13.65

Price Target Revisions

1 Month
-25.52%
3 Months
-25.52%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for ALDX. The average price target is 7.34 USD. This implies a price increase of 308% is expected in the next year compared to the current price of 1.8.
The average price target has been revised downward by 25.52% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALDX Current Analyst RatingALDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ALDX Historical Analyst RatingsALDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
ALDX was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ALDX.
In the previous month the buy percentage consensus was at a similar level.
ALDX was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-18HC Wainwright & Co.Downgrade Buy -> Neutral
2025-11-10BTIGReiterate Buy -> Buy
2025-05-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-07BTIGMaintains Buy -> Buy
2025-04-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-03HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-09HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-02HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-06OppenheimerReiterate Outperform -> Outperform
2024-05-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-03OppenheimerUpgrade Perform -> Outperform
2024-04-02HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-17OppenheimerDowngrade Outperform -> Perform
2023-10-17CitigroupMaintains Buy -> Buy
2023-08-09OppenheimerReiterate Outperform -> Outperform
2023-06-30HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-22HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-16HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-01CitigroupMaintains Buy -> Buy
2023-05-05HC Wainwright & Co.Reiterate Buy
2023-03-10HC Wainwright & Co.Reiterate Buy
2023-03-01HC Wainwright & Co.Reiterate Buy
2022-06-09CitigroupMaintains Buy
2021-12-21SVB LeerinkMaintains Outperform
2021-12-21CitigroupMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 5, 2026
Period
Q2 / 2026
EPS Estimate
-$0.14
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
13.94%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-86.67%
EPS (3 Months)
-86.67%

Next Earnings Summary

ALDX is expected to report earnings on 8/5/2026. The consensus EPS estimate for the next earnings is -0.14 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ALDX revenue by date.ALDX revenue by date.
N/AN/A
-39.34%		N/A
350.80%		N/A
147.36%		N/A
21.49%		N/A
-14.09%		N/A
-2.39%
EBITDA
YoY % growth
ALDX ebitda by date.ALDX ebitda by date.
-11.97M-18.66M
-55.89%		-22.45M
-20.31%		-39.63M
-76.53%		-56.4M
-42.32%		-34.61M
38.63%		-55.96M
-61.69%		-62.42M
-11.54%		-42.531M
31.86%		-59.867M
-40.76%		-35.013M
41.52%		N/A
56.20%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ALDX ebit by date.ALDX ebit by date.
-11.99M-18.7M
-55.96%		-22.49M
-20.27%		-39.7M
-76.52%		-56.5M
-42.32%		-34.67M
38.64%		-56.22M
-62.16%		-62.68M
-11.49%		-42.794M
31.73%		-60.117M
-40.48%		-35.265M
41.34%		N/A
11.73%		N/A
58.88%		N/A
1,095.12%		N/A
-37.94%		N/A
19.62%		N/A
16.84%		N/A
-7.66%
Operating Margin
ALDX operating margin by date.ALDX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ALDX eps by date.ALDX eps by date.
-1.40-1.67
-19.29%		-1.40
16.17%		-1.90
-35.71%		-2.23
-17.37%		-1.12
49.78%		-1.07
4.36%		-1.06
1.04%		-0.64
39.62%		-0.94
-46.88%		-0.56
40.43%		N/A
15.76%		N/A
32.97%		N/A
129.03%		N/A
2,205.56%		N/A
27.47%		N/A
-54.63%		N/A
-2.50%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.14
13.94%		-0.13
2.32%		-0.11
-9.65%
Revenue
Q2Q % growth		2.04M6.992M
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-8.199M
19.37%		-6.747M
15.67%		-3.742M
43.88%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALDX Yearly Revenue VS EstimatesALDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
ALDX Yearly EPS VS EstimatesALDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
29.34%
EPS Next 5 Year
46.80%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
45.14%
Revenue Next 5 Year
55.83%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ALDEYRA THERAPEUTICS INC / ALDX Forecast FAQ

What is the price target for ALDX stock?

12 analysts have analysed ALDX and the average price target is 7.34 USD. This implies a price increase of 308% is expected in the next year compared to the current price of 1.8.

When does ALDEYRA THERAPEUTICS INC (ALDX) report earnings?

ALDEYRA THERAPEUTICS INC (ALDX) will report earnings on 2026-08-05.

What are the consensus estimates for ALDEYRA THERAPEUTICS INC (ALDX) next earnings?

The consensus EPS estimate for the next earnings of ALDEYRA THERAPEUTICS INC (ALDX) is -0.14 USD and the consensus revenue estimate is 0 USD.

Can you provide the analyst count for ALDEYRA THERAPEUTICS INC stock?

The number of analysts covering ALDEYRA THERAPEUTICS INC (ALDX) is 12.